B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PRMT7

MOLECULAR TARGET

protein arginine methyltransferase 7

UniProt: Q9NVM4NCBI Gene: 544961 compounds

PRMT7 (protein arginine methyltransferase 7) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PRMT7

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine0.691

About PRMT7 as a Drug Target

PRMT7 (protein arginine methyltransferase 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented PRMT7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PRMT7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.